IMR Press / CEOG / Volume 35 / Issue 4 / pii/1630639214484-1491866722

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Review
High-grade cervical intraepithelial neoplasia, human papillomavirus and factors connected with recurrence following surgical treatment
Show Less
1 Department of General Pathology, 2Department of Immunology, 3Department of Gynecology and Obstetrics, Institute of Oncological Research (IPON), Federal University of the Triângulo Mineiro (UFTM), Uberaba, Minas Gerais (Brazil)
Clin. Exp. Obstet. Gynecol. 2008, 35(4), 248–251;
Published: 10 December 2008
Abstract

Although effective strategies for preventing cancer of the uterine cervix exist, this disease continues to be a serious health problem worldwide, especially in developing countries. Today, the role of human papillomavirus (HPV) as a causal factor for the emergence of cervical cancer and its precursor lesions is well established, and prevention programs against cervical cancer are based on detecting cervical intraepithelial neoplasia (CIN). HPV present immunological evasion mechanisms that inhibit detection of the virus by the host, which may result in persistent chronic infection and irrevocably comprise the host defenses. Conization is the surgical technique most used for treating high-grade CIN, since it makes it possible to exclude invasive neoplasia, evaluate resection margins and preserve fertility. However, several factors have been considered to be indicators for residual disease. This review had the aim of covering some factors relating to persistence and recurrence of high-grade CIN following conization.
Keywords
Cervical intraepithelial neoplasia
Human papillomavirus
Conization
Recurrence
Immunological response
Share
Back to top